JP2022517865A5 - - Google Patents
Info
- Publication number
- JP2022517865A5 JP2022517865A5 JP2021543528A JP2021543528A JP2022517865A5 JP 2022517865 A5 JP2022517865 A5 JP 2022517865A5 JP 2021543528 A JP2021543528 A JP 2021543528A JP 2021543528 A JP2021543528 A JP 2021543528A JP 2022517865 A5 JP2022517865 A5 JP 2022517865A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- cdr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962797573P | 2019-01-28 | 2019-01-28 | |
| US62/797,573 | 2019-01-28 | ||
| PCT/US2020/015457 WO2020160022A1 (en) | 2019-01-28 | 2020-01-28 | Compositions and methods for treatment of diseases involving cxcl1 function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022517865A JP2022517865A (ja) | 2022-03-10 |
| JP2022517865A5 true JP2022517865A5 (enExample) | 2023-02-03 |
Family
ID=71841416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543528A Pending JP2022517865A (ja) | 2019-01-28 | 2020-01-28 | Ｃｘｃｌ１機能に関与する疾患の治療のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US11292832B2 (enExample) |
| EP (1) | EP3917949A4 (enExample) |
| JP (1) | JP2022517865A (enExample) |
| CN (1) | CN113544143A (enExample) |
| CA (1) | CA3127943A1 (enExample) |
| WO (1) | WO2020160022A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4471057A4 (en) * | 2022-01-27 | 2026-03-04 | Chiome Bioscience Inc | ANTI-CXCL1 HUMAN ANTIBODY |
| WO2026060413A1 (en) * | 2024-09-16 | 2026-03-19 | Calgent Biotechnology Co., Ltd. | Single chain antibodies and use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1930445B1 (en) * | 2005-09-02 | 2010-03-31 | Toray Industries, Inc. | Kit and method for detection of urothelial cancer |
| US7858752B2 (en) | 2006-12-05 | 2010-12-28 | Abbott Laboratories | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same |
| CN101261275A (zh) * | 2008-01-23 | 2008-09-10 | 李力 | 一种用于早期卵巢癌诊断的检测试剂盒 |
| JP5617638B2 (ja) | 2008-10-29 | 2014-11-05 | 日本ゼオン株式会社 | 燃料ホース用の架橋性ニトリル共重合体ゴム組成物の製造方法および燃料ホース用のゴム架橋物 |
| CA2742157A1 (en) * | 2008-10-31 | 2010-05-06 | Toray Industries, Inc. | Immunoassay method for human cxcl1 protein |
| US9487582B2 (en) | 2010-01-08 | 2016-11-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methods for treating pancreatic cancer |
| AU2014207321A1 (en) * | 2013-01-21 | 2015-07-23 | Abbvie Inc. | Anti-TNF and anti-IL17 combination therapy biomarkers for inflammatory disease |
| US9290570B2 (en) | 2013-03-15 | 2016-03-22 | Eli Lilly And Company | Pan-ELR+ CXC Chemokine Antibodies |
| KR20160021125A (ko) | 2013-05-17 | 2016-02-24 | 쌩뜨레 나티오날 데 라 르세르쉬 생띠끄 (씨. 엔. 알. 에스) | 항-cxcl1, cxcl7 및 cxcl8 항체 및 이들의 용도 |
| WO2019055776A2 (en) * | 2017-09-14 | 2019-03-21 | Rosser Charles | COMPOSITIONS AND METHODS FOR TREATING DISEASES INVOLVING CXCL1 FUNCTION |
| US11603569B2 (en) * | 2018-03-20 | 2023-03-14 | Cedars-Sinai Medical Center | Immune modulating genes for prognosis, diagnosis and treatment of metastatic disease, and drug identification methods thereof |
-
2020
- 2020-01-28 EP EP20747679.7A patent/EP3917949A4/en active Pending
- 2020-01-28 CN CN202080017507.1A patent/CN113544143A/zh active Pending
- 2020-01-28 US US16/982,456 patent/US11292832B2/en active Active
- 2020-01-28 JP JP2021543528A patent/JP2022517865A/ja active Pending
- 2020-01-28 WO PCT/US2020/015457 patent/WO2020160022A1/en not_active Ceased
- 2020-01-28 CA CA3127943A patent/CA3127943A1/en active Pending
-
2022
- 2022-03-07 US US17/688,740 patent/US11760796B2/en active Active
-
2023
- 2023-08-18 US US18/451,872 patent/US20240018229A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024038003A5 (enExample) | ||
| JP2022177090A5 (enExample) | ||
| JP2025016349A5 (enExample) | ||
| JP2009539348A5 (enExample) | ||
| JP2020505919A5 (enExample) | ||
| JP2022519118A5 (enExample) | ||
| JP2020508655A5 (enExample) | ||
| CN113354729A (zh) | 一种抗新型冠状病毒的单克隆抗体及其应用 | |
| JP2020514277A5 (enExample) | ||
| JP2023093753A5 (enExample) | ||
| JP2023520969A5 (enExample) | ||
| JP2018517431A5 (enExample) | ||
| JP2023071956A5 (enExample) | ||
| RU2009111884A (ru) | Последовательности вариабельных областей моноклональных антител против il-31 и способы использования | |
| JP2012525829A5 (enExample) | ||
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| JP2024105229A5 (enExample) | ||
| JP2021530244A5 (enExample) | ||
| JP2011527899A5 (enExample) | ||
| JP2011526249A5 (enExample) | ||
| CN113354730B (zh) | 一种抗新型冠状病毒的单克隆抗体及其应用 | |
| JP2024024114A5 (enExample) | ||
| WO2021129891A1 (zh) | 可结合cd4的多肽及其应用 | |
| JP2020513759A5 (enExample) | ||
| JP2024516098A5 (enExample) |